Ledger.Open graph →
SEC Form D · Amendment · filed June 2, 2014

Endosee Corp

Offering
$2.6M
Sold
$1.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LOS ALTOS, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Thomas Gengler · Dublin 2, IrelandExec · DirectorSusan Hallenberg · Salt Lake City, UTExec · DirectorDr. Thomas G. Roberts, Jr · San Francisco, CAExecShih-Ping (Bob) Wang · Los Altos, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗